NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
March 12, 2026
March 12, 2026
March 12, 2026
March 12, 2026
March 11, 2026
March 11, 2026
March 10, 2026
March 9, 2026
March 9, 2026
March 6, 2026
March 6, 2026
March 4, 2026
March 3, 2026
March 3, 2026
March 2, 2026
February 27, 2026
February 27, 2026